Point72 Asia (Singapore)’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Point72 Asia (Singapore)’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,654	Closed	-$105K	–	1608
2024 Q1	$105K	Buy	6,654 +3,863	+138%	+$59.5K	0.03%	633
2023 Q4	$45K	Buy	+2,791	New	+$35.6K	0.01%	328

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Point72 Asia (Singapore)'s DCPH Position: Q2 2024 in Review

Point72 Asia (Singapore) sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 6,654 shares — an estimated $105K sold.

Point72 Asia (Singapore) first reported a position in DCPH in Q4 2023 and held it in 2 quarters. The position peaked at $105K in Q1 2024. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Point72 Asia (Singapore) reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Point72 Asia (Singapore) sold 6,654 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $105K.
Point72 Asia (Singapore) first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
Point72 Asia (Singapore)'s Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $105K in Q1 2024.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Point72 Asia (Singapore)'s 13F filing for Q2 2024, filed 14 Aug 2024.